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Summary
A group of 55 black men with mild or moderate hypertension
who were being treated with methyldopa, prazosin, and a
thiazide diuretic in combination with sotalol, were studied
before and after changing their treatment to captopril and a
thiazide diuretic. The level of blood pressure control was
similar in the 11 men with mild hypertension but the 44 men
with moderate hypertension were less well controlled with
captopril and a thiazide diuretic. In the men with moderate
hypertension the mean increase in the systolic blood pressure
after the change in treatment was 4,7 mmHg (not significant)
and in the diastolic pressure 6,2 mmHg (P < 0,02). The mean
blood pressure was higher during treatment with captopril in
37 men and lower in 18 men (P = 0,01). Thirty-seven men
found both regimens acceptable and 33 of these men pre-
ferred the captopril regimen; however, 15 men said they did
not like the captopril regimen while only 4 men did not like
the methyldopa/prazosin regimen (P < 0,01). Side-effects
from the captopril regimen were reported by 18 of the men
and from the methyldopa/prazosin regimen by 6 men (P <
0,02). It was concluded that the captoprillthiazide regimen
was less effective than the methyldopa/prazosin/sotalol/
thiazide regimen for the control of moderate hypertension in
this population of black men. Although the men who liked
both regimens preferred the captopril regimen, that regimen
was associated with significantly more side-effects and was
disliked by more of the men than was the methyldopa/pra-
zosin regimen.
S Atr Med J 1990; 78: 455-456.
The angiotensin-convening enzyme (ACE) inhibitors are
believed to be effective agents in the treatment of moderate
hypenension. Captopril with or without a thiazide diuretic is
said to have a high level of patient acceptabilityl,2 and has been
recommended in place of triple drug therapy.3
In this study, captopril with a thiazide diuretic was evaluated
in a group of black goldminers with mild or moderate hyper-
tension, who were being treated with a combination of
methyldopa, prazosin and hydrochlorothiazide in combination
with sotalol.
Patients and methods
Men with mild or moderate hypertension (initial diastolic
blood pressures:::;; 120 mmHg) attending the Ernest Oppen-
heimer Hospital Hypenension Clinic and who were receiving
methyldopa 500 mg twice a day, prazosin 2 mg twice aday
and hydrochlorothiazide 25 mg daily in a combination tablet
with sotalol 160 mg (methyldopa/prazosin regimen) were
invited to attend the clinic to participate in the study. At mid-
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morning they were evaluated by two blood pressure measure-
ments taken by an enrolled nurse using a Dynamap Vital
Signs Monitor 845XT. The patients were seated for approxi-
mately 5 minutes before having their blood pressure measured.
The men were told that the purpose of their visit was to
evaluate a different treatment regimen and that those who
agreed would be required to attend the clinic again in 1
month. The men were then seen individually by a physician
who repeated the purpose of their visit and confirmed their
willingness to participate. Each man was asked whether he
suffered any side-effecrs from his present treatment regimen.
The men who agreed to participate then stopped their methyl-
dopa/prazosin regimen and started treatment with captopril
50 mg twice daily and hydrochlorothiazide 25 mg daily
(captopril regimen). At the second visit, 1 month later, blood
pressure measurements were repeated at the same time of the
day, in the same room, by the same technique, by the same
enrolled nurse using the identical apparatus. The men were
again seen by the physician and asked about side-effects from
the captopril regimen. Each man was asked which of the
regimens he preferred. Treatment was then continued in
accordance with the degree of control and, if this was similar,
in accordance with the patient's preference.
The second blood pressure reading at each visit was used for
the analysis. The measurements made at the first visit are
taken to reflect the effect of the methyldopa/prazosin regimen
and those at the second visit, 4 weeks later, to reflect the effect
of the captopril regimen. Each man served as his own control
and the blood pressures were analysed as paired data. The data
were analysed by a paired {-test for continuous variables and
by McNemar's test for dichotomous variables.
Results
A total of 65 men attended for the first visit, all of whom had
been on the methyldopa/prazosin regimen for at least 1 month;
all agreed to participate in the study. One man was withdrawn
5 days after starting the captopril regimen because he developed
severe dizziness. Nine of the remaining 64 men failed to attend
for their second visit. Only the 55 men who completed the
trial have been included in the study. In 11 of these men, the
initial pretreatment diastolic blood pressure had been > 94
mmHg and < 105 mmHg and in 44 men it had been> 104
mmHg and :::;; 120 mmHg. The ambient temperature in the
clinic was 24°C on each of the days of the study. The mean
age of the patients was 43,0 ± 9,95 years. Three men had
pretreatment blood urea levels> 6,5 mmo1/1 (6,7, 7,2 and 12,9
mmo1/1).
In the 11 men with mild hypertension, systolic, diastolic,
and mean blood pressures (diastolic blood pressure - (pulse
pressure X 0,33)) were not significantly different with the two
regimens. However, in the 44 men with moderate hypertension,
the captopril/thiazide mean blood pressure was higher than
the methyldopa/prazosin mean blood pressure in 30 men (x 2
df 1 = 5,8; P < 0,02). The systolic blood pressure did not difter
signilicantly between the two regimens but the mean difference
in diastolic blood pressure was 6,2 ± 15,64 mmHg higher with
the captopril/thiazide regimen in the 44 men with moderate
hypertension (P < 0,02). Side-effects were more frequently
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noted during the captopriVthiazide treatment period (X2 df
I = 7,2; P < 0,01). CaptopriVthiazide-associated side-effects
were noted by 18 men; these included excess sweating (8
men), tiredness (4), abdominal discomfort (2), impotence (2)
and coughing (2). Six men noted side-effects during the
methyldopalprazosin treatment period; drowsiness (5) and
impotence (3).
The majority of patients (37) were satisfied with both
regimens. One patient liked neither regimen. Fifteen men did
not like the captopril regimen and 4 did not like the methyl-
dopalprazosin regimen (X 2 df I = 7,1; P < 0,01). Thirty-three
of the 37 men who found both regimens acceptable, preferred
the captopril regimen.
Discussion
The two regimens studied may not be strictly comparable
although each would be considered to be suitable for the
management of moderate hypertension. In black subjects with
hypertension, renin levels are usually 10w4 and ACE inhibitors
alone have been shown to be relatively ineffective.5 However,
with the addition of a thiazide diuretic, ACE inhibitors have
been used successfully for the control of hypertension in black
South Mricans.5 The present study has shown that the ACE
inhibitor/thiazide diuretic regimen was less effective than the
methyldopalprazosin regimen in controlling the blood pressure
in black men with moderate hypertension.
The men who found both regimens acceptable expressed a
preference for captopril, which lends support for the view that
patients on captopril feel beter than do those on other anti-
hypertensive regimens.' On the other hand, the captopril
regimen was tolerated by significantly fewer men than was the
methyldopalprazosin regimen.
The methyldopalprazosin regimen is less expensive and, in
this study, was more acceptable and more effective than the
captopril regimen.
I wish to thank Mr Emest Mbeka for organising the special
clinics for the study and Mr Simon TIadi who did all the blood
pressure measurements. Professor F. J. Milne kindly reviewed the
manuscript.
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Long-term efficacy and safety of




The long-term efficacy and safety of sustained-release dil-
tiazem (Tilazem; Parke-Davis) were evaluated. A total of 27
young, physically active patients with hypertension were
followed up for 17 months. On a dosage of 90 mg twice daily,
adequate blood pressure reduction was obtained in 23
patients (85%). No adverse effects were noted.
S AIr Med J 1990; 78: 456-457.
In a previously published double-blind parallel study the
short-term antihypertensive efficacy of sustained-release (SR)
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diltiazem (Tilazem; Parke-Davis) was compared with that of
atenolol.' The study was extended in order to evaluate the
long-term efficacy and safety of the SR formulation of dil-
tiazem.
Patients and methods
The study comprised 27 patients and the fIrst phase - the
comparison of the antihypertensive efficacy of SR diltiazem
with that of atenolol' - lasted 5 months. On termination of
this phase, 14 patients controlled on SR diltiazem were followed
up for another 12 months. The 13 patients on atenolol were
switched to SR diltiazem 90 mg twice daily and followed up
for another 17 months. :.
The patients were all men and were specifically selected on'
the basis of youth (mean age 32 ± 2 years) and being physically
active. 1
Patients were evaluated at monthly intervals in the morning
12 - 14 hours after their last dose of SR diltiazem. Blood
pressure was measured by conventioI].al mercury sphygmo-
manometry in triplicate at rest, after 5 minutes in the supine
